Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CMS

Biden’s long-term care agenda faces headwinds - Roll Call

Biden wants more workers to care for the elderly and disabled, but Medicaid reimbursement rates and workforce shortages hinder his ambitions.

Roll Call

Biden administration targets unexpected health costs

WASHINGTON -- The Biden White House announced a trio of steps aimed at protecting patients from unexpected health care costs on Friday, with new actions surrounding short-term health plans, surprise medical bills and medical debt.

Tribune News Service

Biden administration targets unexpected health costs - Roll Call

The White House announced a trio of steps Friday aimed at protecting patients from unexpected health care costs.

Roll Call

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

The Independent UK

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Tribune News Service

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call

MP warns FA Cup will be ‘forever diminished’ by rights deal with Premier League

PA understands the FA is discussing the possibility of allowing overseas FA Cup rights to be sold alongside those of the Premier League.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

Roll Call

Medicare To Negotiate Drug Prices, Lower Costs

CMS releases guidance on using authority to expand benefits, reduce drug costs, and strengthen Medicare program.

Zenger

Eight new UK laws passed in the last week explained - including prisoner release dates, rogue landlords and more

A number of Bills have been granted royal assent by the King this week - here's what they all mean

Manchester Evening News

Regulator must hold football to account over discrimination, says CMS committee

Club action plans on EDI must be mandated and assessed by a regulator, the CMS committee said.

The Independent UK

HHS has limited options as millions lose Medicaid

WASHINGTON -- States are disenrolling residents from Medicaid at a breakneck pace, even though a large percentage of those losing coverage are still eligible for the program.

Tribune News Service

HHS has limited options as millions lose Medicaid - Roll Call

States are booting millions off of the Medicaid rolls, but the Biden administration has few options to keep people from losing health care.

Roll Call

Does Medicare pay for Alzheimer's drugs? The answer is complicated and changing

There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Fraudsters are duping homeless people into signing up for ACA plans they can’t afford

MIAMI — Mary Zhelyazkova was surprised when pharmacists at Florida’s largest safety net hospital said they could not fill her prescription.

Wales Online

ITV boss says Phillip Schofield relationship was 'deeply inappropriate'

Carolyn McCall appeared before a UK Culture Media and Sport Committee parliamentary inquiry on Wednesday morning

The Independent UK

Biden administration urges states to slow down on dropping people from Medicaid

The Biden administration is urging states to slow down their efforts to remove people from Medicaid

Axios

Experimental Alzheimer's drug endorsed for full approval by FDA advisers

Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

The digital health divide is working against many people on Medicare. How some groups want to address this 'urgent problem'

Among people age 65 and older, just 44% use tablets and only 61% have smartphones, according to Pew Research Center.

Tribune News Service

Thousands face Medicaid whiplash in South Dakota and North Carolina

Until recently, Jonathon Murray relied on Medicaid to pay for treatments for multiple health conditions, including chronic insomnia. Murray, a 20-year-old restaurant worker from the college town of Brookings, South Dakota, said that without his medication, he would stay awake for several nights in a row.

Tribune News Service

Medicare Advantage supplemental health plans draw scrutiny

WASHINGTON — Medicare Advantage plans lure customers with television ads promising plans with dental, vision and hearing benefits that traditional Medicare doesn’t offer

AVNetwork

Unpacking the True Value of Digital Signage SaaS

Software as a Service (SaaS) has been a popular business model in the IT sector for years and is now rapidly expanding in the digital signage world, delivering unmatched benefits for end users and AV integrators alike. However, true digital signage SaaS solutions are few and far between.

Roll Call

Medicare Advantage supplemental health plans draw scrutiny - Roll Call

Though supplemental benefits often draw seniors to Medicare Advantage plans, insurance experts question their value.

Chicago Tribune

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

WEKU

Hospitals create police forces to stem growing violence against staff

Georgia is the latest state to enact a law that allows hospitals to create independent police forces. Critics worry the law enforcement focus could have unintended consequences.

1 … 13 14 15 16

People

Chiquita BrooksLaSure

14 stories

David Lipschutz

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.